Management of Neonatal Jaundice

Patient Assessment and Risk Stratification

The American Academy of Pediatrics recommends that clinical status, including whether the infant is sick or well-appearing, affects treatment thresholds for neonatal jaundice 1, 2

The American Academy of Pediatrics suggests ensuring adequate feeding and hydration to help with bilirubin excretion, and recommends verifying infant feeding, assessing for dehydration, and documenting weight gain 4
For follow-up timing, the American Academy of Pediatrics recommends measuring total serum bilirubin (TSB) 8-12 hours after stopping phototherapy and the following day for infants who received phototherapy less than 48 hours of age, and TSB within 1-2 days after any phototherapy for all other infants 3

The American Academy of Pediatrics recommends using intensive phototherapy with blue-green spectrum light, requiring spectral irradiance greater than 30 μW/cm²/nm, and bringing special blue fluorescent tubes as close to the infant as possible if phototherapy becomes necessary 1
The American Academy of Pediatrics suggests escalating care immediately if TSB reaches exchange transfusion threshold, typically greater than 25-30 mg/dL for term infants without hemolysis, or if signs of acute bilirubin encephalopathy are present 3, 5

The American Academy of Pediatrics recommends following infants with hemolytic disease more closely, keeping bilirubin less than 17.5-23.4 mg/dL, and considering bilirubin/albumin ratio as an additional risk factor 2